ferric ferrocyanide has been researched along with Neuroblastoma in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Burga, RA; Fernandes, R; Kale, SS; Subramony, JA; Sweeney, EE; Sze, RW; Tuesca, A; Zun, Z | 1 |
| Cano-Mejia, J; Fernandes, R; Sweeney, EE | 1 |
| Bookstaver, ML; Cano-Mejia, J; Fernandes, R; Jewell, CM; Sweeney, EE | 1 |
3 other study(ies) available for ferric ferrocyanide and Neuroblastoma
| Article | Year |
|---|---|
Composite iron oxide-Prussian blue nanoparticles for magnetically guided T
Topics: Animals; Contrast Media; Female; Ferric Compounds; Ferrocyanides; Gadolinium; Humans; Magnetic Resonance Imaging; Magnetics; Mice, Inbred Strains; Nanoparticles; Neuroblastoma; Phototherapy; Signal-To-Noise Ratio; Theranostic Nanomedicine; Xenograft Model Antitumor Assays | 2017 |
Photothermal Therapy Generates a Thermal Window of Immunogenic Cell Death in Neuroblastoma.
Topics: Animals; Cell Death; Cell Line, Tumor; Female; Ferrocyanides; Humans; Hyperthermia, Induced; Mice; Nanoparticles; Neuroblastoma; Phototherapy; Vaccination | 2018 |
Prussian blue nanoparticle-based antigenicity and adjuvanticity trigger robust antitumor immune responses against neuroblastoma.
Topics: Adjuvants, Immunologic; Animals; CD8-Positive T-Lymphocytes; Cell Line, Tumor; Cell Proliferation; Female; Ferrocyanides; Hydrogen-Ion Concentration; Mice; Nanoparticles; Neuroblastoma; Oligodeoxyribonucleotides; Phototherapy | 2019 |